miR-26a inhibits the proliferation and migration of prostate cancer by targeting CDC6

Minerva Med. 2021 Oct;112(5):661-663. doi: 10.23736/S0026-4806.20.06479-4. Epub 2020 Mar 12.

Authors

Hui Li¹, Weiran Xu², Tian Wang³, Chengfan Yu³, Xiaosong Rao⁴, Xin Hong³, Xiaofeng Wang³

Affiliations

¹ Department of Urologic Surgery, Peking University International Hospital, Beijing, China - look_aya@163.com.
² Department of Internal Medicine-Oncology, Peking University International Hospital, Beijing, China.
³ Department of Urologic Surgery, Peking University International Hospital, Beijing, China.
⁴ Department of Pathology, Peking University International Hospital, Beijing, China.

PMID: 32166936
DOI: 10.23736/S0026-4806.20.06479-4

No abstract available

Publication types

Letter

MeSH terms

Cell Cycle Proteins / metabolism*
Cell Line, Tumor
Cell Movement*
Cell Proliferation*
Humans
Luciferases / metabolism
Male
MicroRNAs / metabolism*
Nuclear Proteins / metabolism*
Prostatic Neoplasms / metabolism*
Prostatic Neoplasms / pathology*
RNA, Messenger / metabolism

Substances

CDC6 protein, human
Cell Cycle Proteins
MIRN26A microRNA, human
MicroRNAs
Nuclear Proteins
RNA, Messenger
Luciferases